Massachusetts General Hospital Cancer Center strives to be a leading provider of continuing medical education to oncology professionals. Our CME offerings focus on cutting edge technologies, treatments and advancements in cancer research and care.
Controversial Cases in Hematologic Malignancies and Hematology 2014
April 11–12, 2014
Colonnade Hotel • Boston, MA
For more information, and to register, click HERE.
Dates: May 6-8th
The Challenge of Cancer in Botswana symposium will address issues surrounding the delivery of cancer care in Botswana.
New Paradigms in Treatment-Resistant Breast Cancer
Click here to view any of 3 webinars related to the topic “New Paradigms in Treatment-Resistant Breast Cancer”. Registration is free and each webinar is CME-certified.
- Treatment Resistant, Hormone-Positive Breast Cancer: Next Steps and New Paradigms
- Triple Negative Breast Cancer: Understanding Treatment Resistance and New Treatment Options
- HER2-Positive Breast Cancer: After Trastuzumab, What’s Next?
Participate in this innovative online activity to find a thorough review of the latest clinical trial data and treatment guidelines for castration-resistant prostate cancer, as well as guidance on the mechanism of action and efficacy of newly approved and late-stage investigational treatments.
U.S. News & World Report ranks the Mass General Cancer Center sixth among U.S. hospitals.
Visit TargetedCancerCare.org for more information on the latest genomic research, cancer treatments and clinical trials.
Your gift of any amount will help us in our mission to advance knowledge and to rapidly translate discovery into exceptional cancer care. Learn more about making a gift, including tribute giving and other ways to get involved.